AI Liquid Biopsy Detects Early Liver Disease & Chronic Illness Signals

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a groundbreaking artificial intelligence (AI)-driven liquid biopsy that analyzes genome-wide patterns of circulating cell-free DNA (cfDNA) fragments in the blood. … Read More